Background: Iron deficiency (ID) is a common comorbidity in patients with heart failure (HF) and is associated with reduced functional capacity, diminished quality of life, and increased mortality. This study aimed to determine the prevalence of ID and its clinical characteristics.Methods: This descriptive cross-sectional study involved 136 patients with chronic HF at the University of… Continue reading Clinical Characteristics of Iron Deficiency in Patients with Chronic Heart Failure at a Major Referral Centre in Southern Nigeria
Tag: Heart Failure
The Impact of Coffee Consumption on Mortality Among Patients With Heart Failure
Aims: To assess the relationship between #coffee consumption and all-cause mortality in heart failure (#HF ) patients, using data from the National Health and Nutrition Examination Survey (NHANES).Methods and results: We analyzed data from NHANES (2003-2018), including 915 participants with HF who reported daily caffeine intake. Participants were categorized into coffee consumption levels: zero, one,… Continue reading The Impact of Coffee Consumption on Mortality Among Patients With Heart Failure
Long-term survival and durable recovery of #heart failure in patients with triglyceride deposit #cardiomyovasculopathy treated with tricaprin
Heart disease is a major global threat. Triglyceride deposit cardiomyovasculopathy (TGCV) is an emerging, noncommunicable, adult-onset heart disease, first identified in Japanese patients with heart failure (HF) requiring cardiac transplantation1,2,3. In TGCV, defective intracellular lipolysis of long-chain triglycerides (TGs) results in cellular steatosis and energy failure mainly in cardiomyocytes4 and smooth muscle cells5, leading to… Continue reading Long-term survival and durable recovery of #heart failure in patients with triglyceride deposit #cardiomyovasculopathy treated with tricaprin
#Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
Summary of Top 10 Key Points1. Approximately 6.7 million Americans over 20 years of age have heart failure (HF), and the prevalence is expected to rise to 8.5 million Americans by 2030.2. The lifetime risk of HF has increased to 24%; approximately 1 in 4 persons will develop HF in their lifetime.3. Approximately 33% of… Continue reading #Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
#Olfactory Impairment and the Risk of Major Adverse #Cardiovascular Outcomes in Older Adults
BackgroundOlfactory impairment is common in older adults and may be associated with adverse cardiovascular health; however, empirical evidence is sparse. We examined olfaction in relation to the risk of coronary heart disease (CHD), stroke, and congestive heart failure (CHF).Methods and ResultsThis study included 2537 older adults (aged 75.6±2.8 years) from the Health ABC (Health, Aging, and… Continue reading #Olfactory Impairment and the Risk of Major Adverse #Cardiovascular Outcomes in Older Adults
#ELECTRONIC NICOTINE PRODUCT USE IS ASSOCIATED WITH INCIDENT #HEART FAILURE – THE ALL OF US RESEARCH PROGRAM
Trajectories of #renal biomarkers and new-onset #heart failure in the general population: Findings from the PREVEND study
Renal dysfunction is one of the most critical risk factors for developing heart failure (HF). However, the association between repeated measures of renal function and incident HF remains unclear. Therefore, this study investigated the longitudinal trajectories of urinary albumin excretion (UAE) and serum creatinine and their association with new-onset HF and all-cause mortality.Methods and resultsUsing… Continue reading Trajectories of #renal biomarkers and new-onset #heart failure in the general population: Findings from the PREVEND study
Association of Rurality With Risk of Heart Failure
Rural populations experience an increased burden of heart failure (HF) mortality compared with urban populations. Whether HF incidence is greater among rural individuals is less known. Additionally, the intersection between racial and rural health inequities is understudied.Objective To determine whether rurality is associated with increased risk of HF, independent of cardiovascular (CV) disease and socioeconomic… Continue reading Association of Rurality With Risk of Heart Failure
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart FailureThe TRANSFORM-HF Randomized Clinical Trial
Although furosemide is the most commonly used loop diuretic in patients with heart failure, some studies suggest a potential benefit for torsemide.Objective To determine whether torsemide results in decreased mortality compared with furosemide among patients hospitalized for heart failure.Design, Setting, and Participants TRANSFORM-HF was an open-label, pragmatic randomized trial that recruited 2859 participants hospitalized with… Continue reading Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart FailureThe TRANSFORM-HF Randomized Clinical Trial
2 Medical News 